Development and pilot testing of the revised Patients’ Attitudes Towards Deprescribing questionnaire for people with cognitive impairment
| Field | Value | Language |
| dc.contributor.author | Reeve, Emily | |
| dc.contributor.author | Anthony, AC | |
| dc.contributor.author | Kouladjian O'Donnell, Lisa | |
| dc.contributor.author | Low, Lee-Fay | |
| dc.contributor.author | Ogle, SJ | |
| dc.contributor.author | Glendenning, JE | |
| dc.contributor.author | Lorang, CE | |
| dc.contributor.author | Hilmer, Sarah N | |
| dc.date.accessioned | 2020-07-21 | |
| dc.date.available | 2020-07-21 | |
| dc.date.issued | 2018-01-01 | en |
| dc.identifier.uri | https://hdl.handle.net/2123/22901 | |
| dc.description.abstract | Objectives: 1) To develop a version of the revised Patients’ Attitude Towards Deprescribing (rPATD) questionnaire for people with mild cognitive impairment and mild-to-moderate dementia (rPATDcog) and 2) capture the beliefs and attitudes of this population and their carers about deprescribing through a pilot study. Methods: Firstly, the rPATDcog was modified from the rPATD and tested in a small group of participants with mild cognitive impairment, then we conducted a pilot study of the rPATDcog and the carers’ rPATD. Results: Twenty-one participants with cognitive impairment and 11 carer participants (forming dyads) participated in this study. Eighty-one percent (17/21) of participants said that they would stop one or more of their medications if their doctor said it was possible. There was excellent agreement of corresponding questions between dyads. Conclusions: The rPATDcog was feasible to administer in this study. Further work is required to provide generalisable results and determine utility in practice. | en |
| dc.language.iso | en | en |
| dc.publisher | Wiley | en |
| dc.relation.ispartof | Australasian Journal on Ageing | en |
| dc.rights | Copyright All Rights Reserved | en |
| dc.title | Development and pilot testing of the revised Patients’ Attitudes Towards Deprescribing questionnaire for people with cognitive impairment | en |
| dc.type | Article | en |
| dc.subject.asrc | 1109 Neurosciences | en |
| dc.subject.asrc | 1115 Pharmacology and Pharmaceutical Sciences | en |
| dc.identifier.doi | 10.1111/ajag.12576 | |
| dc.relation.nhmrc | APP1105777 | |
| usyd.faculty | SeS faculties schools::Faculty of Medicine and Health | en |
| usyd.citation.volume | 37 | en |
| usyd.citation.issue | 4 | en |
| usyd.citation.spage | E150 | en |
| usyd.citation.epage | E154 | en |
| workflow.metadata.only | No | en |
Associated file/s
Associated collections